Revisiting RIP
The shift to home sleep testing is forcing a rethink of how respiratory effort is captured, validated, and clinically applied.
The shift to home sleep testing is forcing a rethink of how respiratory effort is captured, validated, and clinically applied.
'The American health care system has joined with commercial partners to define sleep apnea in a way that allows both parties to generate revenue from a multitude of pricey diagnostic studies, equipment sales, and questionable treatments.'
The data show sustained improvements from baseline that were highly consistent with the previously published 6-, 12-, 24-, and 36-month results.
The Respicardia remedē system is an implantable pacemaker-like battery pack that stimulates the phrenic nerve.
Read MoreHighmark Blue Cross Blue Shield and its affiliates will provide coverage for the Respicardia Inc’s remedē System implantable therapy for central sleep apnea, effective immediately.
Read MoreThe trial seeks to explore whether transvenous stimulation can improve airway physiology.
Read MoreInhibiting the production of hydrogen sulfide in rats resulted normal breathing patterns becoming gasping patterns.
Read MoreHighlights from the 5-year data show sustained improvements that were consistent with the published 6-, 12-, 24-, and 36-month results.
Read MoreCentral sleep apnea was common in patients with pacing-induced cardiomyopathy and may improve with cardiac resynchronization therapy compared with right ventricular pacing, researchers found.
Read MoreA cardiologist and a sleep physician discuss: how to screen cardiology patients for SDB, PSG versus HST for diagnosis, and treatment options.
Read MorePhysicians who use Inspire upper airway stimulation, Respicardia’s remedē, and Avery’s diaphragm pacemaker share their stories.
Read MoreBut a new retrospective population-based study finds higher-than-expected frequencies of death, dementia, and arrhythmias.
Read MoreAvery Biomedical Devices has earned FDA approval for its next-generation diaphragm pacemaker transmitter, Spirit, and indications for use include chronic respiratory insufficiency due to central sleep apnea.
Read MoreThe webinar Comparison of Various Forms of PAP Therapies for Sleep-disordered Breathing in Heart Failure, produced by Sleep Review and sponsored by Philips Respironics, is available for free and immediate on-demand viewing.
Read MorePublished research suggests, due to sex differences in kidney function, women may gain more renal benefits from sleep apnea treatment than men. “Chronic kidney disease is a growing epidemic worldwide, highlighting the...
Read MorePatients and medical providers should be aware that chronic opioid use can interfere with sleep by...
Read MoreThe Positive Airway Pressure (PAP) Systems Guide compares 7 CPAPs side-by-side.
Read MoreCould a chemical produced by the brain that regulates mood, sleep, and breathing also be...
Read More